Viatris Inc.

NASDAQ:VTRS

8.98 (USD) • At close March 13, 2025
Bedrijfsnaam Viatris Inc.
Symbool VTRS
Munteenheid USD
Prijs 8.98
Beurswaarde 10,719,336,200
Dividendpercentage 4.31%
52-weken bereik 8.77 - 13.55
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Scott Andrew Smith
Website https://www.viatris.com

An error occurred while fetching data.

Over Viatris Inc.

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious

Vergelijkbare Aandelen

BioMarin Pharmaceutical Inc. logo

BioMarin Pharmaceutical Inc.

BMRN

70.6 USD

Bio-Techne Corporation logo

Bio-Techne Corporation

TECH

59.88 USD

Insulet Corporation logo

Insulet Corporation

PODD

244.67 USD

Alnylam Pharmaceuticals, Inc. logo

Alnylam Pharmaceuticals, Inc.

ALNY

241.75 USD

Henry Schein, Inc. logo

Henry Schein, Inc.

HSIC

69.81 USD

Incyte Corporation logo

Incyte Corporation

INCY

67.71 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)